Reach further, in an Open Access Journal Endocrinology, Diabetes & Metabolism Case Reports

ISSN 1470-3947 (print)
ISSN 1479-6848 (online)

Searchable abstracts of presentations at key conferences in endocrinology

Published by BioScientifica
Endocrine Abstracts (2007) 14 P354 

Endothelial function and hemostasis factors in hypothyroidism and subclinical hyperthyroidism

Annamaria Gazdag1, Endre Nagy V1, Emma Varga1, Laszlo Samson1, Annamaria Erdei1 & Zoltan Jenei2

Author affiliations

Long-term follow-up of differentiated thyroid cancer (DTC) patients requires yearly measurements of serum thyroglobulin (Tg) levels is endogenous (4 weeks off-thyroxin) or exogenous (human recombinant TSH injection) high TSH state. Subclinical hyperthyroidism is maintained in the patients throughout the rest of the year. We examined the endothelial function, hemostasis factors and metabolic parameters in short-term iatrogenic hypothyroidism (HO) and in subclinical hyperthyroidism (SH) in patients with DTC. In seventeen patients who had undergone total thyroidectomy and radioiodine ablation, blood pressure (RR), Tg, thyroid function, lipid parameters, homocystein, CRP, fibrinogen, von Willebrandt factor activity (vWF), flow-mediated vasodilatation (FMD) and nitroglycerin-mediated vasodilatation of the brachial artery in HO (TSH=89.82±29.36 mU/L) and in SH (TSH=0.24±0.11 mU/L) were measured. The study protocol has been approved by the institutional ethics committee. In HO the FMD was markedly lower than in SH (6.79±4.44 vs.14.37±8.33%, P<0.001), whereas the vasodilatation in response to nitroglycerine was not different between HO and SH (28.20±8.33 vs. 29.27±14.19%, ns). RR did not significantly differ in HO and SH (128.62±7.17/82.29±3.98 vs. 125.8±7.05/85.2±5.8 Hgmm, ns). Total cholesterol (7.34±1.23 vs. 4.75±/1.24 mmol/L, P<0.002), LDL-cholesterol (4.55±1.10 vs. 2.70±0.89 mmol/L, P<0.001) and homocystein (12.95±4.49 vs. 9.62±2.3 μmol/L, P<0.01) were significantly higher in HO than in SH. Triglyceride (1.79±1.12 vs. 1.03±0.73 mmol/L) and HDL-cholesterol (1.95±0.47 vs. 1.58±0.42 mmol/L) were similar in HO and SH. Fibrinogen (3.23±0.50 vs. 4.38±0.84 g/L, P<0.01), vWF activity (90.09±25.92 vs.130.62±29.97%, P<0.001) and CRP (4.12±4.67 vs. 5.32±5.15 mg/L, P<0.05) were lower in HO. In conclusion, FMD, fibrinogen and vWF activity was found to be lower in HO than in SH. Thyroxin normalizes the low FMD in HO patients.

This Issue/Conference

Article tools

My recent searches